The SME IPO market remains active in late January 2026, with nutraceutical and wellness companies gaining traction due to rising health awareness. Accretion Nutraveda IPO is one such upcoming issue, and investors are closely watching the Accretion Nutraveda IPO GMP to gauge early market sentiment ahead of subscription.
This short update highlights key IPO details, price band, important dates, GMP status, and investor considerations.
Accretion Nutraveda IPO Overview
Accretion Nutraveda IPO is a bookbuilt SME issue of ₹24.77 crore, consisting entirely of a fresh issue of 19.20 lakh equity shares. The company plans to use the proceeds for business expansion, manufacturing upgrades, working capital, and growth initiatives in the nutraceutical and Ayurvedic products segment.
Key Highlights
Issue Size: ₹24.77 crore
Fresh Issue: 19,20,000 shares
Issue Type: Book Built
Listing Platform: BSE SME
Important Dates
IPO Opens: January 27 / January 28, 2026 (as per official confirmation)
IPO Closes: January 30, 2026
Allotment (Expected): February 2, 2026
Refunds: February 3, 2026
Tentative Listing: February 4, 2026
Price Band & Lot Size
The IPO price band is fixed at ₹122 to ₹129 per share.
Lot Size: 1,000 shares
Retail Minimum: 2 lots (2,000 shares)
Retail Investment: ₹2,58,000 (at upper price band)
HNI Minimum: 3 lots (3,000 shares) – ₹3,87,000
Accretion Nutraveda IPO GMP Status
As the IPO is yet to open, the Accretion Nutraveda IPO GMP is currently reported as ₹0 (flat) or TBA in the grey market. This indicates neutral sentiment in the preissue phase, which is common before bidding begins.
Note: GMP is unofficial and can change rapidly once subscription starts. It should not be treated as a guaranteed indicator of listing performance.
IPO Strengths & Risks
Strengths
Strong growth potential in nutraceutical and Ayurvedic sectors
100% fresh issue focused on capacity expansion
Bookbuilt issue enables better price discovery
Manufacturing certifications enhance business credibility
Risks
Flat preissue GMP indicates limited early excitement
Higher minimum investment for retail investors
SME stocks may face postlisting liquidity challenges
Competitive and regulated nature of the nutraceutical industry
Top 5 FAQs on Accretion Nutraveda IPO GMP
1. What is Accretion Nutraveda IPO GMP today?
Currently, the GMP is ₹0 (flat) in the preopen phase.
2. When does Accretion Nutraveda IPO open?
The IPO is expected to open on January 27 or January 28, 2026 (as per final confirmation).
3. What is the price band of Accretion Nutraveda IPO?
The price band is ₹122 to ₹129 per share.
4. What is the minimum investment for retail investors?
Retail investors need to invest ₹2,58,000 for 2,000 shares at the upper band.
5. Where will Accretion Nutraveda IPO be listed?
The IPO will be listed on the BSE SME platform, tentatively on February 4, 2026.
Final Note
The Accretion Nutraveda IPO GMP is currently flat ahead of the issue opening, reflecting neutral early sentiment. Investors should focus more on the company’s fundamentals, sector growth outlook, and risk profile rather than relying solely on grey market signals.
Disclaimer: This content is for informational purposes only and does not constitute investment advice.
Post a Comment